annb0t
Top 20
Dr. Reddy's Laboratories Ltd (NYSE: RDY) has agreed to acquire the U.S. generic prescription product portfolio of Australia-based Mayne Pharma Group Limited (OTC: MAYND) (OTC: MAYNF) (OTC: MYPHY). Under the terms of the agreement, Dr. Reddy's will acquire the portfolio for an upfront payment of approximately $90 million in cash, with contingent payments of up to $15 million. Consideration towards inventory and credits for certain accrued channel liabilities are to be determined on the closing da...
>>> Read more: Dr. Reddy's Seeks Gaining Foothold In Women's Health Via Mayne Pharma's U.S. Generic Prescription Deal
>>> Read more: Dr. Reddy's Seeks Gaining Foothold In Women's Health Via Mayne Pharma's U.S. Generic Prescription Deal
